切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2014, Vol. 03 ›› Issue (06) : 359 -362. doi: 10.3877/cma.j.issn.2095-3232.2014.06.007

所属专题: 文献

临床研究

保留半肝动脉血流的肝门阻断在肝细胞癌肝切除术中的应用
李川江1, 邹衍泰1, 林建华1, 方学军1, 崔忠林1, 周杰1,()   
  1. 1. 510515 广州,南方医科大学南方医院肝胆外科
  • 收稿日期:2014-07-16 出版日期:2014-12-10
  • 通信作者: 周杰
  • 基金资助:
    南方医院院长基金(2012B014)

Use of hepatic portal occlusion without hemihepatic artery control in liver resection for hepatocelluar carcinoma

Chuanjiang Li1, Yantai Zou1, Jianhua Lin1, Xuejun Fang1, Zhonglin Cui1, Jie Zhou1,()   

  1. 1. Department of Hepatobiliary Surgery, Nanfang Hospital of Southern Medical University, Guangzhou 510515, China
  • Received:2014-07-16 Published:2014-12-10
  • Corresponding author: Jie Zhou
  • About author:
    Corresponding author: Zhou Jie, Email:
引用本文:

李川江, 邹衍泰, 林建华, 方学军, 崔忠林, 周杰. 保留半肝动脉血流的肝门阻断在肝细胞癌肝切除术中的应用[J]. 中华肝脏外科手术学电子杂志, 2014, 03(06): 359-362.

Chuanjiang Li, Yantai Zou, Jianhua Lin, Xuejun Fang, Zhonglin Cui, Jie Zhou. Use of hepatic portal occlusion without hemihepatic artery control in liver resection for hepatocelluar carcinoma[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2014, 03(06): 359-362.

目的

探讨保留半肝动脉血流的肝门阻断(半肝阻断)在肝细胞癌(肝癌)肝切除术中的应用价值。

方法

回顾性分析2007年1月至2013年1月在南方医科大学南方医院肝胆外科行肝切除术的422例肝癌患者临床资料。所有患者均签署知情同意书,符合医学伦理学规定。根据术中采用入肝血流阻断法不同将患者分为半肝阻断组(140例)和Pringle组(282例)。半肝阻断组男114例,女26例;平均年龄(45±12)岁;采用半肝阻断法,沿肝固有动脉向上解剖游离出健侧肝动脉支,其余肝蒂包括患侧肝动脉、全肝门静脉及胆管以阻断带阻断。Pringle组男230例,女52例;年龄(47±13)岁;采用Pringle阻断法。比较两组手术时间,阻断时间,术中出血量,术后5 d内血ALT、TB峰值和术后并发症发生情况。观察两组患者2007~2009年和2010~2013年两个时间段数量的变化。两组数据比较采用t检验,率的比较采用χ2检验。

结果

半肝阻断组患者术后5 d内血ALT、TB峰值分别为(179±53)U/L、(24±9)μmol/L,Pringle组相应为(291±126)U/L、(30±15)μmol/L,差异有统计学意义(t=-12.757,-5.777;P<0.05)。两组手术时间、阻断时间、术中出血量、术后并发症发生率比较差异无统计学意义(P>0.05)。2007~2009年半肝阻断组患者占24.2%(53/219),2010~2013年升至42.9%(87/203);2007~2009年Pringle组患者占75.8%(166/219),2010~2013年降至57.1% (116/203),两组数量变化差异有统计学意义(χ2=16.540,P<0.05)。

结论

与Pringle阻断法相比,采用保留半肝动脉血流的肝门阻断法患者肝癌肝切除术后肝损害较轻,其临床应用近年有增加趋势。

Objective

To investigate the value of hepatic portal occlusion without hemihepatic artery control (hemihepatic occlusion) in liver resection for hepatocelluar carcinoma (HCC).

Methods

Clinical data of 422 patients with HCC undergoing liver resection in Department of Hepatobiliary Surgery, Nanfang Hospital of Southern Medical University from January 2007 to January 2013 were retrospectively analyzed. The informed consents of all patients were obtained and the ethical committee approval was received. The patients were divided into two groups according to the different hepatic inflow occlusions: the hemihepatic occlusion group (n=140) and Pringle maneuver group (n=282). There were 114 males and 26 females in the hemihepatic occlusion group with a mean of (45±12) years old. Hemihepatic occlusion was performed in this group and the hepatic arterial branch of the healthy side was dissected up along the proper hepatic artery. The other hepatic pedicles including hepatic artery of the diseased side, hepatic portal vein and bile duct were occluded with occluding straps. There were 230 males and 52 females in the Pringle maneuver group with a mean of (47±13) years old and Pringle maneuver was performed. The differences were compared between two groups in the operation time, occlusion time, intraoperative blood loss, peak levels of blood alanine aminotransferase (ALT), total bilirubin (TB) within 5 days after operation and incidence of postoperative complications. The variation of patient quantity in the periods of 2007-2009 and 2010-2013 in two groups was observed. The data between two groups were compared by t test and the comparison of ratio was conducted by Chi-square test.

Results

The peak levels of blood ALT, TB within 5 days after operation were (179±53) U/L, (24±9) μmol/L in hemihepatic occlusion group and were (291±126) U/L, (30±15) μmol/L in Pringle maneuver group accordingly, where significant differences were observed (t=-12.757, -5.777; P<0.05). There was no significant difference in the operation time, occlusion time, intraoperative blood loss and incidence of postoperative complications between two groups (P>0.05). From the year 2007 to 2009, the patients undergoing hemihepatic occlusion accounted for 24.2% (53/219) and increased to 42.9% (87/203) during the year 2010-2013. From the year 2007 to 2009, the patients undergoing Pringle maneuver accounted for 75.8% (166/219) and decreased to 57.1% (116/203) during the year 2010-2013. Significant difference was observed in the variation of patient quantity between two groups (χ2=16.540, P<0.05).

Conclusions

Compared with the Pringle maneuver, the hepatic portal occlusion without hemihepatic artery control causes lighter liver damage after liver resection in patients with HCC and it has been gradually widely used in clinic in recent years.

表1 半肝阻断组和Pringle组肝癌患者肝切除术围手术期情况的比较(±s
[1]
高杰,朱继业.卫生部《原发性肝癌诊疗规范(2011年版)》解读[J].中华普通外科杂志,2012, 27(8):693-695.
[2]
Shiba H, Ishida Y, Fujiwara Y, et al. Practice to minimize the use of blood products improve outcome after hepatic resection for hepatocellular carcinoma[J]. Hepatogastroenterology, 2013, 60(127):1681-1683.
[3]
Liu L, Miao R, Yang H, et al. Prognostic factors after liver resection for hepatocellular carcinoma: a single-center experience from China[J]. Am J Surg, 2012, 203(6):741-750.
[4]
胡智明,邹寿椿,赵大建.肝切除术中肝血流阻断技术的合理应用[J].中国医药科学,2011, 1(19):9-11.
[5]
Lau WY, Lai EC, Lau SH. Methods of vascular control technique during liver resection: a comprehensive review[J]. Hepatobiliary Pancreat Dis Int, 2010, 9(5):473-481.
[6]
Gurusamy KS, Sheth H, Kumar Y, et al. Methods of vascular occlusion for elective liver resections[J]. Cochrane Database Syst Rev, 2009(1):CD007632.
[7]
Smyrniotis VE, Kostopanagiotou GG, Contis JC, et al. Selective hepatic vascular exclusion versus Pringle maneuver in major liver resections: prospective study[J]. World J Surg, 2003, 27(7):765-769.
[8]
Nagano H, Kishimoto S, Kobayashi S, et al. A safe protocol of intermittent hilar vascular clamping for hepatic resection in cirrhosis[J]. Hepatogastroenterology, 2009, 56(94/95):1439-1444.
[9]
李清汉,甄作均,陈应军,等.经肝门板半肝阻断在肝细胞肝癌切除术中的应用研究[J/CD].中华肝脏外科手术学电子杂志,2012, 1(3):157-161.
[10]
Chen XP, Qiu FZ. A simple technique ligating the corresponding inflow and outflow vessels during anatomical left hepatectomy[J]. Langenbecks Arch Surg, 2008, 393(2):227-230.
[11]
马军,陈大治,哈若水,等.CT灌注成像对肝硬化血流动力学分析及肝硬化程度评估的相关性研究[J].宁夏医学杂志,2011, 33(5):385-387.
[12]
Jin S, Dai C, Yang Y, et al. Effect of hepatic blood inflow occlusion without hemihepatic artery control on apoptosis of liver cells in rats[J]. Hepatogastroenterology, 2010, 57(97):35-40.
[13]
Jin S, Dai CL. Hepatic blood inflow occlusion without hemihepatic artery control in treatment of hepatocellular carcinoma[J]. World J Gastroenterol, 2010, 16(46):5895-5900.
[14]
开喆,张启林,史皖庆.保留一侧入肝动脉血流阻断在肝肿瘤切除中的应用[J].蚌埠医学院学报,2012, 37(9):1069-1071.
[15]
Lee KF, Cheung YS, Wong J, et al. Randomized clinical trial of open hepatectomy with or without intermittent Pringle manoeuvre[J]. Br J Surg, 2012, 99(9):1203-1209.
[16]
Sanjay P, Ong I, Bartlett A, et al. Meta-analysis of intermittent Pringle manoeuvre versus no Pringle manoeuvre in elective liver surgery[J]. ANZ J Surg, 2013, 83(10):719-723.
[1] 王春荣, 陈姜, 喻晨. 循Glisson蒂鞘外解剖、Laennec膜入路腹腔镜解剖性左半肝切除术临床应用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 37-40.
[2] 李建美, 邓静娟, 杨倩. 两种术式联合治疗肝癌合并肝硬化门静脉高压的安全性及随访评价[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 41-44.
[3] 杜锡林, 谭凯, 贺小军, 白亮亮, 赵瑶瑶. 肝细胞癌转化治疗方式[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 597-601.
[4] 魏小勇. 原发性肝癌转化治疗焦点问题探讨[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 602-607.
[5] 张其坤, 商福超, 李琪, 栗光明, 王孟龙. 联合脾切除对肝癌合并门静脉高压症患者根治性切除术后的生存获益分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 613-618.
[6] 严庆, 刘颖, 邓斐文, 陈焕伟. 微血管侵犯对肝癌肝移植患者生存预后的影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 624-629.
[7] 廖梅, 张红君, 金洁玚, 吕艳, 任杰. 床旁超声造影对肝移植术后早期肝动脉血栓的诊断价值[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 630-634.
[8] 段文忠, 白延霞, 徐文亭, 祁虹霞, 吕志坚. 七氟烷和丙泊酚在肝切除术中麻醉效果比较Meta分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 640-645.
[9] 张文华, 陶焠, 胡添松. 不同部位外生型肝癌临床病理特点及其对术后肝内复发和预后影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 651-655.
[10] 韩宇, 张武, 李安琪, 陈文颖, 谢斯栋. MRI肝脏影像报告和数据系统对非肝硬化乙肝患者肝细胞癌的诊断价值[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 669-673.
[11] 唐灿, 李向阳, 秦浩然, 李婧, 王天云, 柯阳, 朱红. 原发性肝脏神经内分泌肿瘤单中心12例诊治与疗效分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 674-680.
[12] 张维志, 刘连新. 基于生物信息学分析IPO7在肝癌中的表达及意义[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 694-701.
[13] 陈安, 冯娟, 杨振宇, 杜锡林, 柏强善, 阴继凯, 臧莉, 鲁建国. 基于生物信息学分析CCN4在肝细胞癌中表达及其临床意义[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 702-707.
[14] 叶文涛, 吴忠均, 廖锐. 癌旁组织ALOX15表达与肝癌根治性切除术后预后的关系[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 708-712.
[15] 吴晨瑞, 廖锐, 贺强, 潘龙, 黄平, 曹洪祥, 赵益, 王永琛, 黄俊杰, 孙睿锐. MDT模式下肝动脉灌注化疗联合免疫靶向治疗肝细胞癌多处转移一例[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 713-716.
阅读次数
全文


摘要